DuPont Decomposition

Why does BAJAJHCARE earn its ROE?

Breaking down Return on Equity into profitability, efficiency, and leverage.

ROE = Net Margin × Asset Turnover × Equity Multiplier

3.0% = 2.6% × 0.66 × 1.73

Latest: FY2026

Profitability

Net Margin

2.6%

10.5% →2.6%

How much profit per ₹ of revenue

Efficiency

Asset Turnover

0.66x

0.94x →0.66x

Revenue per ₹ of assets

Leverage

Equity Multiplier

1.73x

2.20x →1.73x

Assets funded by equity vs debt

Trend Analysis

ROE declined by 18.8 pp over 5 years. Driven by net margin declining (10.5% → 2.6%), asset turnover declining (0.94x → 0.66x), leverage falling (2.20x → 1.73x).

Historical Decomposition

Last 5 years

YearRevenuePATNet MarginAsset TOLeverageROE
FY20220Cr0Cr10.5%0.942.2021.7%
FY20230Cr0Cr6.7%0.722.4411.7%
FY20240Cr-0Cr-17.7%0.622.75-30.1%
FY20250Cr0Cr7.3%0.651.798.5%
FY20260Cr0Cr2.6%0.661.733.0%

How to read DuPont

  • Rising ROE from margin = pricing power, operational improvement (good)
  • Rising ROE from turnover = better asset utilization (good)
  • Rising ROE from leverage = more debt, amplified risk (caution)
  • Falling ROE across all three = structural deterioration (red flag)

See DCF fair value for BAJAJHCARE

Combine financial quality with intrinsic value.

See Fair Value →

DuPont decomposition from audited annual financials. Factual analysis, not investment advice.

BAJAJHCARE DuPont Analysis — ROE 3.0% | YieldIQ